OCT 08, 2016 5:16 PM PDT

Gut Microbes can Assist Chemotherapy Drugs

WRITTEN BY: Carmen Leitch
Humans have a symbiotic relationship with microorganisms, many of which reside in our gastrointestinal tract, and they can be highly beneficial to our health. New work, reported in the journal Immunity, has indicated that there are two species of bacteria in our gut that can activate cells of our immune system to increase the efficacy of a common anticancer therapeutic. 
 
Scanning electron micrograph of a human T cell / Credit: Wikipedia

The bacteria, Enterococcus hirae and Barnesiella intestinihominis, have a role in the activation of immune responses to cancer that involve T cells, which boosts the effects of a chemotherapy drug. The researchers found that the microbe-assisted immune response led to longer survival without additional cancer growth in patients with advanced lung and ovarian cancer that have been given chemo-immunotherapy.

"The anti-cancer drug's efficacy relies on a complex interplay between the microbiome of cancer patients and their ability to mount an efficient immune memory response against some bacteria of the gut microbiota," explained the co-senior author of the study, Mathias Chamaillard, Research Director of the Center for Infection and Immunity of Lille (Inserm/CNRS/Lille University/Institut Pasteur de Lille). "This paradigm opens the way to improve treatment design by either optimizing the use of antibiotics, or implementing supplementation with so-called oncomicrobiotics or their bioactive metabolites, to promote the efficacy of anti-cancer drugs."

Previous work has demonstrated that some gut microbes are able to encourage the growth of tumors, but some are protective against cancer. While in some cases intestinal bacteria can improve the impact of chemotherapy agents, the mechanism this process has remained unclear, as has the identity of the bacterial species that are able to do so. 
 
E. hirae restored the efficacy of CTX in antibiotics-treated mice, E. hirae and B. intestinihominis enhanced cognate anticancer immune responses, NOD2 receptors limit the bioactivity of E. hirae and B. intestinihominis / Credit: Immunity Daillère et al

This new research has shown that E. hirae and B. intestinihominis both work to orchestrate the effects of the chemotherapy drug cyclophosphamide, which is an immunosuppressant used to treat many different types of cancers. The abstract for the publication is shown in the image above. Mouse models were utilized to illustrate that after oral treatment with E. hirae, the antitumor T cell response was activated  in the spleen along with the direct lethal effects of cisplatin on a tumor, thus reducing tumor growth. A similar effect was shown in oral treatment of B. intestinihominis;  T cells infiltration of various mouse tumors was promoted.

To follow up on the results, the blood T cell responses of 38 patients with advanced lung and ovarian cancer and chemotherapy treatment were analyzed. The investigators learned that memory T cell immune responses specific to E. hirae and B. intestinihominis predicted progression-free survival - the amount of time that a patient lives has the disease, but without it getting worse, during and after treatment.

The researchers hope to identify the exact microbial metabolites or molecules impacting the immune system that can enhance the effects of cyclophosphamide. "Answering this question may provide a way to improve the survival of cyclophosphamide-treated cancer patients by supplementing them with bacterial-derived drugs instead of live microorganisms," Chamaillard concluded.

Sources: Eurekalert!/AAAS via Cell Press, Immunity
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 22, 2020
Microbiology
MAR 22, 2020
The Benefits of Being a Loner
Outliers exist everywhere in nature, and it seems they serve an important purpose.
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
MAY 01, 2020
Microbiology
MAY 01, 2020
Once Thought to Make COVID-19 Worse, ACE Inhibitors Now Tested as Therapeutic
Researchers were once concerned that blood pressure medications may increase the risk of infection, or make an infection ...
MAY 10, 2020
Microbiology
MAY 10, 2020
We Still Don't Know Why Rat Hepatitis is Turning Up in People
Hepatitis is a term for liver inflammation. Hepatitis A, B, C, D, and E are caused by viruses.
MAY 15, 2020
Immunology
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
MAY 17, 2020
Coronavirus
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
Loading Comments...